April 28, 2021

Educational Sessions Explore Sustainability, Myopia Management and Toric Lens Opportunities for Eye Care Professionals

SAN RAMON, Calif., April 28, 2021—At the first in-person industry event of the year, CooperVision welcomes SECO 2021 attendees to become partners in protecting the planet and in addressing tough vision challenges such as astigmatism and myopia. CooperVision and CooperVision Specialty Eyecare will champion these commitments in Booth #835 and during several educational sessions throughout the show.

“Improving the way people see each day takes leadership, innovation and partnership. This is at the core of our work and what we look forward to sharing with attendees at SECO 2021,” said Melissa Kiewe, Vice President of Marketing, Americas, CooperVision. “From opening our Brilliant Futures™ Myopia Management Program certification training to all U.S. ECPs to making clariti® 1 day the first net plastic neutral contact lens,1 we continuously enhance our portfolio of products, programs, and tools to help ECPs meet the needs of their patients.”

Innovation in Myopia Management and Myopia Control

When visiting the booth, SECO attendees can learn more about CooperVision’s extensive portfolio, including MiSight® 1 day contact lenses designed for myopia control†2 in age-appropriate patients* and specialty lenses, such as Paragon CRT®, for myopia management.

Attendees are also invited to stop by the booth to speak with Brilliant Futures™ certified ECPs who can discuss their experiences with and provide insights on prescribing MiSight® 1 day. The experts will be in the booth on Friday, April 30 from 10 to 11 a.m., 1 to 2:15 p.m., and 4:15 to 5 p.m., and on Saturday, May 1 from 10 to 11 a.m., 1 to 2 p.m., and 3:15 to 4 p.m. Read more about our experts here.

“Once myopia progresses, there’s no going back. It changes a child’s quality of life and ocular health for the rest of their lives3,” said Justin Kwan, OD, Senior Manager, Myopia Management, CooperVision. “It’s critical that eye care professionals take action, especially during a time when the realities of pandemic lifestyles may be exacerbating myopia progression4 for children worldwide.”

Partnering for Sustainability with Plastic Neutral clariti® 1 day

Expanding on CooperVision’s record of sustainable manufacturing and operations, the company recently announced that through a partnership with Plastic Bank®, clariti® 1 day has become the first net plastic neutral contact lens in the United States.1 For every box of clariti® 1 day distributed in the U.S., CooperVision funds the collection, processing, and reuse of general plastic waste that is equal to the weight of the plastic contained in clariti® 1 day lenses and packaging.5

ECPs and students can learn more about how continuous improvements to clariti® 1 day support eye care professionals, their patients, and the health of our planet at the booth. Additionally, students are welcome to attend a lunch symposium, “clariti® 1 day: Continuous Improvement,” presented by Steven Rosinski, OD, Senior Manager, Professional & Academic Affairs, CooperVision on Saturday, May 1 at noon in the Chapter Room.

Leadership in Torics

As the market leader in toric contact lenses,6 CooperVision has developed a portfolio that enables eye care professionals to fit more astigmatic patients than ever in contact lenses. From Biofinity® toric—the most prescribed toric lens on the market7—to MyDay® toric and clariti® 1 day toric, there is a lens for every eye. And with CooperVision’s OptiExpert app, finding the right fit and ensuring the best outcomes for patients has never been easier, and the opportunity for practices has never been better.

SECO attendees can learn more at Booth #835. AHP providers are also welcome to attend a lunch symposium, “The Toric Lens Opportunity,” presented by Dr. Rosinski on Friday, April 30, at noon in Room 411/412.

# # #

 

*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

Compared to a single vision 1 day lens

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com

Media Contact
Hannah Barry, Associate Counselor, McDougall Communications
hannah@mcdougallpr.com or +1(585) 645-8985

 

1 Based on top four global contact lens manufacturers. CVI data on file 2020. Sustainability report, clariti® 1 day in US.

2 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567.

3 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60.

4 Wang J, Li Y, Musch DC, Wei N, Qi X, Ding G, Li X, Li J, Song L, Zhang Y, Ning Y, Zeng X, Hua N, Li S, Qian X. Progression of Myopia in School-Aged Children After COVID-19 Home Confinement. JAMA Ophthalmol. 2021 Jan 14:e206239. doi: 10.1001/jamaophthalmol.2020.6239. Epub ahead of print. PMID: 33443542; PMCID: PMC7809617.

5 Amount is defined as weight. Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways.  CooperVision purchases credits equal to the weight of plastic in clariti® 1 day orders in a specified time period.  clariti® 1 day plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink). CVI data on file 2020. Sustainability report, clariti® 1 day in US.

6 CVI data on file, 2019. US industry reports and internal estimates. Based on monthly toric fit data.

7 CVI data on file 2019. US industry reports and internal estimates. Toric fit data.

8 CooperVision data on file, 2017 – 2019. Based on number of US soft contact lens fits. Includes CooperVision branded and customer-branded equivalent lenses. US industry reports and internal estimates.

9 CVI data on file 2020. Kubic masked online survey; n = 400 US ODs who prescribe toric soft CLs. 77% CVI, 31% Alcon, 41% JJV; p<0.05